ArticleThe lancet. Diabetes & endocrinology2021

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials.

Naveed Sattar et al.PubMed ↗Publisher ↗

No numbers read from the abstract.